FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · IEX Real-Time Price · USD
4.530
+0.030 (0.67%)
Jul 22, 2024, 10:06 AM EDT - Market open
FibroBiologics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
164.31M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionFBLG News
- 7 days ago - FibroBiologics to Present at JonesTrading Healthcare Summit 2024 - GlobeNewsWire
- 27 days ago - FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology - GlobeNewsWire
- 5 weeks ago - FibroBiologics Set to Join Russell 2000® Index - GlobeNewsWire
- 6 weeks ago - FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024 - GlobeNewsWire
- 2 months ago - FibroBiologics Announces 2024 Annual Meeting of Stockholders - GlobeNewsWire
- 2 months ago - FibroBiologics Files 2024 First Quarter Report - GlobeNewsWire
- 2 months ago - FibroBiologics to Present at the BIO International Convention 2024 - GlobeNewsWire
- 3 months ago - FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office - GlobeNewsWire